Results 201 to 210 of about 51,588 (239)

Short-term anabolic agent and sequential therapy to improve bone mineral density and bone turnover markers in patients with osteoporotic hip fractures. [PDF]

J Orthop Surg Res
Park JY, Lim JY, Kim TK, Cho BW, Kwon HM, Park KK, Lee WS.   +6 more
europepmc   +1 more source

A guide to the types, structures, and multifaceted functions of matrix metalloproteinases in cancer

The FEBS Journal, EarlyView.
Matrix metalloproteinases (MMPs) orchestrate cancer progression and metastasis through proteolytic and non‐proteolytic actions. By remodeling the tumor microenvironment, enhancing growth factor availability, and modulating cell behavior, MMPs promote proliferation, migration or invasion, and epithelial‐to‐mesenchymal transition. Alongside extracellular
Zoi Piperigkou, Sylvia Mangani, Spyros Kremmydas, Nikolaos E. Koletsis, Nikos K. Karamanos   +4 more
wiley   +1 more source

Bisphosphonate and statin: adverse effects of co-medication on wound healing in in vitro models of periodontal tissues. [PDF]

Acta Odontol Scand
Småland-Reksten A, Agger AE, Lian AM, Reseland JE, Krüger TB.   +4 more
europepmc   +1 more source

Behind the scenes: how the EMILIN/Multimerin family shapes the cancer landscape

The FEBS Journal, EarlyView.
The EMILIN/Multimerin family members regulate key hallmarks of cancer—including apoptosis, angiogenesis, metastasis, and tumor microenvironment remodeling. As indicated, their function in immune evasion, drug resistance, and metabolic reprogramming remains largely unexplored.
Evelina Poletto, Naike Casagrande, Emanuele Di Siena, Greta Carobolante, Lucrezia Camicia, Giorgia Schinello, Samanta Muzzin, Enrica Timis, Paola Spessotto, Maurizio Mongiat   +9 more
wiley   +1 more source

Genetic variations and clinical implications of B-thalassemia in Iraqi population. [PDF]

PLoS One
Jawad AZ, Chelly M, Al-Zuhairy SH, Bouaziz H.   +3 more
europepmc   +1 more source

Anemia‐associated mutations disrupt the CDIN1‐Codanin1 complex in inherited congenital dyserythropoietic anemia I (CDA‐I) disease

The FEBS Journal, EarlyView.
Congenital dyserythropoietic anemia type I (CDA‐I) arises from mutations in Codanin1 and CDIN1. Using quantitative biophysical approaches, we show that disease‐associated mutations disrupt the CDIN1‐Codanin1 complex. Our findings provide critical insights into the molecular mechanism that links protein dysfunction to disturbing chromatin arrangement ...
Martin Stojaspal, Tomas Brom, Ivona Nečasová, Tomáš Janovič, Pavel Veverka, Naina Verma, Lukáš Uhrík, Lenka Hernychova, Ctirad Hofr   +8 more
wiley   +1 more source

Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis. [PDF]

BMC Musculoskelet Disord
Zhang Y, Cui W, Hou L.
europepmc   +1 more source

Hesperetin modulates osteoprogenitor cells and macrophages under zoledronic acid and inflammatory stress. [PDF]

Arch Oral Biol
Mendes Soares IP, Liepman O, Anselmi C, Chang S, Hebling J, Dal-Fabbro R, Bottino MC.   +6 more
europepmc   +1 more source

Malignant transformation in patients with monoclonal gammopathy of undetermined significance treated with teriparatide for osteoporosis: a bicenter retrospective study and analysis of the French national pharmacovigilance database. [PDF]

Arch Osteoporos
Cassez R, Cortet B, Bouvard B, Theis D, Potey C, Manier S, Paccou J, Philippoteaux C.   +7 more
europepmc   +1 more source

Comparative study on the efficacy of menadione, zoledronic acid, and calcitriol in combination with PKP for the treatment of osteoporotic vertebral compression fractures in extremely elderly patients. [PDF]

Medicine (Baltimore)
Yu H, Hou H, Jin Y.
europepmc   +1 more source